Skip to content
GLP-1 Scorecard
Menu
Graded #416

Arc-1

Arc-1 offers compounded semaglutide (from $249.99) and compounded tirzepatide (from $299.99) as per-dose purchases, not monthly subscriptions.

Visit Arc-1We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Semaglutide
$200/mo (0.5 mg dose, compounded)
Tirzepatide
$200/mo (2.5 mg dose, compounded)
Coverage
Coverage not published
Brand-name
Compounded only

Weigh Arc-1 against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. Because Arc-1 dispenses compounded medication, it’s worth understanding whether compounded semaglutide is legit and safe.

Factor breakdown

Each of the six graded dimensions. See the methodology.

Cost value44/100
Dose & formulation54/100
Clinical oversight72/100
Labs & monitoring52/100
Fulfillment62/100
Contract terms61/100

Strengths

  • Both compounded semaglutide and tirzepatide available
  • Per-dose purchasing — no subscription or membership required
  • 25% off plus free shipping promotion
  • Broader longevity formulary (rapamycin, NAD+, sermorelin)
  • LegitScript Certified badge now displayed on product pages

Where it loses points

  • No legal entity name or address disclosed
  • State availability not disclosed
  • No named clinicians or pharmacy partners
  • Per-dose pricing still climbs with dose (semaglutide 2.5mg is $549.99/mo, tirzepatide 7.5mg $399.99/mo)

Bottom line — Grade C

Best for: Patients seeking per-dose compounded GLP-1 without subscriptions.

Ranked #416 of 499 on this scorecard. See our top-scoring pick, CoreAge Rx (#1), for comparison.

Closest on the board

The boards grading nearest Arc-1 — the realistic shortlist.

The 21 boards nearest this one

View full scorecard rankings →

Pricing/verification reflect Arc-1's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Arc-1's site. Not medical advice; see our disclosure.

← Back to the scorecard